In this review four parameters relevant to the grafting of hemopoietic
stem cells (HSC) are analyzed: the nature and amounts of grafted HSC,
the sources of HSC and the ''in vivo'' fate of the grafted cells. One
may oppose cells with short-term repopulating ability to cells with l
ong-term reconstitutive capacity. The former comprise progenitors, whi
le the latter consist of primitive stem cells, corresponding to murine
pre-colony forming units-spleen (pre-CFU-S) (and to some murine CFU-S
) or to human pre-colony forming units (pre-CFU). In the mouse, the nu
mber of progenitors involved in short-term reconstitution is large, wh
ile that of primitive cells operating months after the transplantation
is reduced. These results may be extrapolated to humans, suggesting t
hat it is possible to engraft a limited number of genetically modified
HSC. However, the administration of large numbers of reconstituting c
ells appears to be a cautionary procedure, since it should insure poly
clonal hemopoiesis, which is the physiological situation in mammals. B
esides marrow, peripheral blood from adult patients treated with chemo
therapy and growth factors, and cord blood from newborns, are promisin
g sources of HSC. Successful engraftment depends not only on the quali
ty and quantity of HSC, but also on the integrity of the marrow microe
nvironment. This microenviromnent may be impaired by chemo- and radiot
herapy, which provides a theoretical basis for the transplantation of
stromal cells along with that of HSC.